Lamotrigine and bipolar disorder: new indication. Only after lithium, like other antiepileptics. Preventive effects in only one aspect of bipolar disorder, but with a risk of Lyell syndrome.
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy / Q000517:prevention & control; D005060:Europe; D006801:Humans; D000077213:Lamotrigine; D008094:Lithium / Q000627:therapeutic use; D055502:Secondary Prevention; D013262:Stevens-Johnson Syndrome / Q000209:etiology; D014227:Triazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000927:Anticonvulsants; D018692:Antimanic Agents; D014227:Triazines; D008094:Lithium; D000077213:Lamotrigine